Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Growth 2024-2030

Global Non-steroidal Anti-inflammatory Drugs for Ophthalmology Market Growth 2024-2030

Non-steroidal anti-inflammatory drugs have been widely used in ophthalmology clinically due to the lack of adverse reactions such as increased intraocular pressure, secondary infection and cataracts caused by glucocorticoids

The global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market size is projected to grow from US$ 909.8 million in 2023 to US$ 1815.5 million in 2030; it is expected to grow at a CAGR of 10.4% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Non-steroidal Anti-inflammatory Drugs for Ophthalmology Industry Forecast” looks at past sales and reviews total world Non-steroidal Anti-inflammatory Drugs for Ophthalmology sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-steroidal Anti-inflammatory Drugs for Ophthalmology sales for 2024 through 2030. With Non-steroidal Anti-inflammatory Drugs for Ophthalmology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-steroidal Anti-inflammatory Drugs for Ophthalmology industry.

This Insight Report provides a comprehensive analysis of the global Non-steroidal Anti-inflammatory Drugs for Ophthalmology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-steroidal Anti-inflammatory Drugs for Ophthalmology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-steroidal Anti-inflammatory Drugs for Ophthalmology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-steroidal Anti-inflammatory Drugs for Ophthalmology.

United States market for Non-steroidal Anti-inflammatory Drugs for Ophthalmology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Non-steroidal Anti-inflammatory Drugs for Ophthalmology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Non-steroidal Anti-inflammatory Drugs for Ophthalmology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Non-steroidal Anti-inflammatory Drugs for Ophthalmology players cover AbbVie, Bausch Health, Bayer, Dossa Pharmaceuticals and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-steroidal Anti-inflammatory Drugs for Ophthalmology market by product type, application, key manufacturers and key regions and countries.

Segmentation by type
Pranoprofen Eye Drops
Diclofenac Sodium Eye Drops
Bromfenac Sodium Eye Drops
Other

Segmentation by application
Hospital
Clinic
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AbbVie
Bausch Health
Bayer
Dossa Pharmaceuticals
GlaxoSmithKline
Janssen Pharmaceuticals
Novartis
Pfizer
Sun Pharmaceutical Industries
Senju Pharmaceutical
Sichuan Heyi Pharmaceutical
Shandong Haishan Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Hangzhou Minsheng Pharmaceutical
Cisen Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-steroidal Anti-inflammatory Drugs for Ophthalmology market?

What factors are driving Non-steroidal Anti-inflammatory Drugs for Ophthalmology market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-steroidal Anti-inflammatory Drugs for Ophthalmology market opportunities vary by end market size?

How does Non-steroidal Anti-inflammatory Drugs for Ophthalmology break out type, application?

Please note: The report will take approximately 2 business days to prepare and deliver.